SyMapCath I/SYMPIONEER S1
Commercial- Indications
- Hypertension
Company intelligence / Profile preview
SyMap Medical
Suzhou, Jiangsu, Chinasymapmedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
SyMap’s msRDN system (SyMapCath I and SymPioneer S1) has been approved in China as a Class III medical device for adjunctive treatment of drug-resistant hypertension. The SMART pivotal trial demonstrated that the msRDN therapy reduced antihypertensive drug burden and controlled office systolic blood pressure to below 140 mm Hg with only four targeted ablations per renal artery. The Elation™ system is being evaluated in a pivotal study for severe asthma via bronchial radiofrequency ablation.
- Therapeutic areas
- PulmonologyCardiovascularOncology
- Modalities
- DeviceRadiofrequency ablation system
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Pythagoras Medical (strategic collaboration on intraarterial nerve mapping platform)TigerMed (clinical CRO partner)
Beyond the preview
Go deeper on SyMap Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SyMap Medical.